Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants (Q28256294)

Toll-like receptor signaling

Europe PubMed Central

title

Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants (English)

0 references

1 reference

Harold F Stills

1

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

ILAR Journal

0 references

volume

46

0 references

page(s)

280-93

0 references

issue

3

0 references

cites work

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Recognition of pathogen-associated molecular patterns by TLR family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Squalene and squalane emulsions as adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

A comparison of commercially available adjuvants for use in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Metabolic Fate of Mineral Oil Adjuvants Using 14C-Labeled Tracers I: Mineral Oil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Toll receptors, CD14, and macrophage activation and deactivation by LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Markers of experimental acute inflammation in the Wistar Han rat with particular reference to haptoglobin and C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Review of Polyclonal Antibody Production Procedures in Mammals and Poultry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

The role of Toll-like receptors in immunity against mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Review of Selected Adjuvants Used in Antibody Production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Toll-like receptor 9: modulation of recognition and cytokine induction by novel synthetic CpG DNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Possibilities of using nanoparticles as carriers for drugs and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Comparison of adjuvants for immune potentiating properties and side effects in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Assessment of side effects induced by injection of different adjuvant/antigen combinations in rabbits and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Immunogenicity of a hybrid Plasmodium falciparum malaria antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Immunomodulation by iscoms, immune stimulating complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Validation of a first-generation Epstein-Barr virus vaccine preparation suitable for human use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

A novel set of hepatic mRNAs preferentially expressed during an acute inflammation in rat represents mostly intracellular proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Taking toll: lipid A mimetics as adjuvants and immunomodulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

The components of the tubercle bacillus responsible for the delayed type of infectious allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Control of Influenza and Poliomyelitis with Killed Virus Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Plasmodium falciparum: the immune response in rabbits to the clustered asparagine-rich protein (CARP) after immunization in Freund's adjuvant or immunostimulating complexes (ISCOMs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Regulation of cytokine gene expression by adjuvants in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280

Current status of immunological adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.46.3.280